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roughness, there is great interest in generic 
approaches that can be used to develop 
adaptive and responsive material systems, 
which in turn can be used for applications 
in biomedicine and biotechnology, such 
as tissue engineering[2] or stem cell culti-
vation.[3] In this context, hybrid material 
systems whose surface is decorated with 
nanoparticles allow a wide range of varia-
tions, since both the solid bulk phase and 
the surface can be tailored to adapt both 
the mechanical and bioinstructive proper-
ties to specific needs. As an example, silica 
nanoparticles (SiNPs), assembled on flat 
surfaces by nonspecific interactions, were 
found to substantially affect the spreading, 
shape, cytoskeletal F-actin alignment, and 
recruitment of focal adhesion complexes 
in endothelial cells and preosteoblasts, 
presumably due to particle size-dependent changes in the nano-
roughness of the surface.[4] Likewise, densely packed layers of 
physiosorbed SiNPs were found to mediate the developmental 
acceleration of hippocampal neurons.[5]
To make this bottom-up approach for the production of 
functional cell culture substrates more efficient and flexible, so 
that even complex particulate architectures can be created in 
a controlled manner on surfaces, we have recently developed 
the DNA-directed immobilization of SiNPs on glass surfaces. 
Both solid[6] and mesoporous[7] SiNPs could be assembled into 
well-defined surface-bound patterns of micrometer dimensions. 
The resulting DNA-decorated SiNP surfaces are highly attractive 
to living cells, which quickly adhere to the particle-decorated 
micropatterns. In analogy to the well-known phenomenon that 
stone pebbles on the sea floor attract marine organisms, we 
have dubbed this surface structuring the “biopebbles” concept. 
Since the particles can be chemically encoded with arbitrary 
dyes, the DNA linkers in between the surface and the nanopar-
ticle can be designed as stable or cleavable, and mesoporous 
SiNPs (MSNs) can be used for encapsulation of cell-instructive 
cargo, the biopebble approach can be exploited to investigate 
basic principles of cell uptake, cell adhesion, and cell guidance 
with micropatterned surfaces.[6,7]
Recently, we showed that surface-bound MSNs can be func-
tionalized with an adenosine triphosphate (ATP)-switchable 
aptamer to respond to global stimuli such as high concentra-
tions of ATP or reducing agents in cell culture medium and 
release an encapsulated cargo.[7] However, the switchability of 
particles by such global parameters is not suitable for achieving 
responsiveness by local changes with high spatial resolution, 
The development of a DNA-based cell-responsive biohybrid interface that can 
be used for spatially confined release of molecular cargo is reported. To this 
end, tailored DNA–protein conjugates are designed as gatekeepers that can be 
specifically cleaved by matrix metalloproteases (MMPs), which are secreted by 
many cancer cells. These gatekeepers can be installed by DNA hybridization 
on the surface of mesoporous silica nanoparticles (MSNs). The MSNs display 
another orthogonal DNA oligonucleotide that can be exploited for site-selective 
immobilization on solid glass surfaces to yield micropatterned substrates for 
cell adhesion. Using the human fibrosarcoma cell line HT1080 that secretes 
MMPs, it is demonstrated that the biohybrid surface is specifically modified by 
the cells to release both MSN-bound gatekeeper proteins and the encapsulated 
cargo peptide KLA. In view of the enormously high modularity of the system 
presented here, this approach promising for applications in drug delivery, 
tissue engineering, or other areas of nanobiotechnology is considered.
The ORCID identification number(s) for the author(s) of this article 
can be found under https://doi.org/10.1002/smtd.202001049.
1. Introduction
The investigation of interactions between cells and synthetic 
material surfaces plays a crucial role in the life sciences to 
understand basic principles of cell adhesion, proliferation, differ-
entiation, and gene expression.[1] Since cellular behavior is influ-
enced by surface properties such as topography, elasticity, and 
© 2021 The Authors. Small Methods published by Wiley-VCH GmbH. 
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for example, to specifically investigate secretion or uptake of 
proteins for individual cells. To design and implement respon-
sive gatekeeper systems that are selectively switched by a stim-
ulus released from single cells, we report here the development 
of a modular supramolecular surface architecture based on 
novel DNA–protein conjugates that can respond to internal cell 
stimuli to control the release of encapsulated cargo from MSNs. 
To this end, we designed a novel class of DNA–protein conju-
gate that is specifically cleavable by matrix metalloproteases 
(MMPs), which are secreted by many cancer cells. The DNA–
protein conjugate was installed as gatekeeper on DNA-function-
alized MSN containers by using one of two orthogonal DNA 
sequences on the MSN (Figure 1), and the resulting constructs 
were then assembled on a glass surface to yield microstructured 
substrates for cell adhesion. Using the human fibrosarcoma 
cell line HT1080 that secretes MMPs, we demonstrate that the 
biohybrid surface can be specifically modified by the cells to 
release particle-bound proteins and low molecular weight cargo.
2. Results and Discussion
To approach the development of the DNA-controlled assembly 
of a cell-switchable biohybrid interface, we selected MMPs as 
triggers with which cells can modify the surface. MMPs are 
calcium-dependent, zinc-containing endopeptidases, which 
play a crucial role in cancer development.[8] They are overex-
pressed and secreted by many cancer cell lines, such as HT1080 
(human, fibrosarcoma), MDA-MB-435 (human, breast cancer), 
and HT29 (human, colorectal adenocarcinoma) cells,[9] and, 
owing to their relatively high concentration in the tumor micro-
environment, MMPs, especially the family members MMP-2/-
9/-14, have already been used as targets for drug delivery.[10] To 
design a modular gatekeeper system, a MMP cleavable peptide 
should be genetically fused with a bulky, traceable protein and 
we selected the enhanced green fluorescent protein (EGFP) 
for this purpose. The resulting fusion protein should be con-
jugated with a DNA oligonucleotide to allow immobilization 
on the particle surface by DNA hybridization. For this purpose, 
bifunctional MSNs were used that contained two different 
orthogonally addressable DNA oligonucleotides. One of the two 
sequences should be used for installing the gatekeeper, whereas 
the other should be used for DNA-directed immobilization of 
the MSN on DNA-patterned glass surfaces (Scheme 1).
2.1. Synthesis of DNA–Protein Gatekeeper Conjugates
To synthesize the desired MMP-sensitive DNA–protein gate-
keeper conjugate, we initially selected peptide sequences 
known to be specifically cleaved by MMPs (Table S1, Supporting 
Information). Since various cleavage sites are reported in the 
literature for MMP-2, -9, or -14, we designed expression plas-
mids for four different MMP–EGFP variants, in the following 
text denoted as gatekeeper (GX) variants, in which X indicates a 
MMP-2/-9 cleave site (G1, G2), a MMP-14 cleavage site (G3), or 
an uncleavable linker (G4), respectively (Table S1; for sequences 
of the primers for plasmid construction, see Table S2 in the 
Supporting Information). The MMP cleavage site was appended 
to the N-terminus of EGFP and additionally supplemented with 
an N-terminal Cys residue to enable the site-selective chemical 
conjugation of DNA oligonucleotides (Scheme  1A). Construc-
tion of plasmids was confirmed by agarose gel electrophoresis 
and the GX variants were expressed in BL21DE3 competent 
Escherichia coli cells and purified by nickel nitrilotriacetic acid 
affinity chromatography using a fast protein liquid chroma-
tography instrument (Figure S1, Supporting Information), as 
previously described.[11] As confirmed by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis, 
the GX protein variants were successfully purified to near 
homogeneity and showed the expected molecular weight of 
≈28 kDa (Figure S2, Supporting Information). Characteriza-
tion by UV–vis and fluorescence spectroscopy confirmed that 
the GX variants exhibit the same optical properties as wild-type 
EGFP (Figure S3, Supporting Information).
The resulting GX variants were then chemically conjugated 
to a DNA oligonucleotide to obtain DNA–protein gatekeeper 
conjugates. The linker DNA length could affect the loading effi-
ciency of the MSN, as a longer oligonucleotide would increase 
the distance between the gatekeeper and the mesopore, which 
could lead to leakage of the encapsulated cargo. By contrast, 
Figure 1. Synthesis and characterization of DNA–protein gatekeeper conjugate. A) Schematic illustration of the synthesis of DNA–protein conjugate 
via bismaleimide cross-linking. B) 16% SDS-PAGE analysis of DNA–protein gatekeeper conjugates with Coomassie blue staining.
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shorter oligonucleotides could cause insufficiently stable 
attachment of the bulky protein to the MSN surface or even lim-
ited steric accessibility for the MMP. Since MMPs have typical 
sizes of about 4 nm in diameter,[12] the 22-mer oligonucleotide 
tF9 was used, which has a nominal length of about 7.5 nm and 
was modified with a 5′-thiol group for chemical coupling (for 
DNA sequences, see Table S3 in the Supporting Information).
For the synthesis of the desired GX–F9 conjugate, the bis-
maleimide cross-linker (1,8-bismaleimido-diethyleneglycol) was 
initially tested, often used to establish intramolecular thiol–thiol 
couplings in proteins.[13] However, we found that it was impos-
sible to purify the desired maleimide-activated GX proteins 
prior to addition of the thiolated DNA. Even at large excess of 
100 equivalents of the cross-linker, very low amounts of the 
desired GX–F9 conjugates were obtained, suggesting that inter-
molecular protein cross-coupling occurred as a dominant side 
reaction (Figure S4, Supporting Information). As an alternative 
conjugation approach, oligonucleotide tF9 was initially activated 
with an excess of the bismaleimide, followed by spin column 
purification and addition of the GX protein to enable the second 
thiol–maleimide coupling (Figure  1A). We found that a large 
excess of cross-linker (100 eq) is inevitable to avoid oligonucleo-
tide dimerization (Figure S5, Supporting Information) and 10 eq 
of maleimide-activated oligonucleotides lead to optimal results 
(Figure S6, Supporting Information). Under these conditions, the 
desired DNA–GX conjugates could be obtained in high yields of 
≈33%, which was greater than the yields obtained in an alterna-
tive cross-linking approach based on the hetero-bispecific cross-
linker sulfosuccinimidyl 4-(N-maleimidomethyl)cyclohexane-
1-carboxylate and amino-derivatized oligonucleotides (≈12% 
yields, see Figures S7 and S8 in the Supporting Information).
Due to the similar structure of the GX variants, all DNA–
protein gatekeeper conjugates (GX–F9) were synthesized by 
using the above-described methodology. The resulting GX–F9 
conjugates were then purified by anion exchange chromatog-
raphy[11,14] (Figures S9 and S10, Supporting Information) and 
further characterized by SDS-PAGE, UV–vis spectroscopy, and 
fluorescence spectroscopy, respectively. As shown in Figure 1B 
and Figure S11 (Supporting Information), the GX–F9 conju-
gates exhibited a reduced electrophoretic mobility, as compared 
to the smaller GX variants. The GX–F9 had a molecular weight 
of ≈38 kDa, as determined by SDS-PAGE, which corresponds 
to the expected value. Furthermore, the GX–F9 conjugates were 
capable of hybridization with their complementary oligonucleo-
tide cF9 (Figure S12, Supporting Information). In agreement 
with previous studies,[11] the binding of the complementary oli-
gonucleotide did not affect the specific UV–vis absorbance and 
emission spectra of the fluorescent protein (Figure S13, Sup-
porting Information). The concentration of the GX–F9 conju-
gates was calculated using calibration samples containing GX 
and F9 mixed at an equimolar ratio of 1:1.
2.2. Protease-Mediated Cleavage of the DNA–Protein 
Gatekeeper Conjugates
We then investigated whether the designed DNA–protein gate-
keeper conjugate can be cleaved from a solid surface by MMPs. 
To simplify the analytical method, streptavidin-coated magnetic 
beads were used as the solid substrate (Figure 2A) onto which 
the biotin-labeled complementary oligomer bcF9 was immobi-
lized. Following that, the so-prepared beads were used for cap-
turing of the GX–F9 conjugates. Quantitative analysis indicated 
that ≈70% of immobilized bcF9 was capable of binding the 
DNA–protein conjugates (Table S4, Supporting Information). 
To investigate the proteolytic cleavage of GX–F9 conjugates, 
and, thus, the functionality of the gatekeeper, we applied the 
collagenase type IV reagent as a model since this reagent is a 
mixture of MMPs including MMP-2 and MMP-9.[15]
Subsequent to the addition of collagenase IV to the bead 
suspension, the fluorescence intensity of the cleaved GX in 
the supernatant was determined at regular time intervals. As 
shown in Figure 2B and Figure S14 (Supporting Information), 
the conjugates G1–F9, G2–F9, and G3–F9 were cleaved off by 
Scheme 1. Schematic illustration of MSNs bearing DNA–protein conjugates as A) a proteinase-responsive gatekeeper and B) the DNA-directed 
immobilization (DDI) of MSNs. Note that the gatekeeper is bound on the MSN surface by one of two orthogonal DNA sequences (green), while the 
other (blue) one can be used for DDI of the MSN construct on surfaces patterned with complementary capture oligonucleotides. The scheme below 
(A) indicates the design of the recombinant gatekeeper protein.
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collagenase IV, whereas experiments with G4–F9 showed no 
substantial release. We found that G1 and G3 were completely 
cleaved from the beads within 2 h, whereas only 80% of G2 was 
released, indicating that the peptide linker sequence of G2 is 
not equally well cleaved by the enzymes in the collagenase IV 
cocktail (Figure S14, Supporting Information). Since G1 showed 
the fastest cleavage kinetics and G4 proved to be a good nega-
tive control as expected, these two conjugates were used for 
further studies. To further examine the sensitivity of G1–F9 
against individual MMPs, this conjugate was also incubated 
with pure MMP-2, -9, and -14, respectively. SDS-PAGE analysis 
showed that about 20% of G1 was released by MMP-2, whereas 
more than 50% of G1 was released by treatment with MMP-9 
and MMP-14, as determined by grayscale analysis (Figure 2C). 
The less efficient cleavage of G1–F9 by the MMP-2 might be 
due to the lower activity of this enzyme, which was also con-
firmed in control experiments with a commercial peptide sub-
strate (Figure S15, Supporting Information).
2.3. Installment of the DNA–Protein Gatekeeper on  
DNA-Functionalized MSNs
To install the DNA–protein gatekeeper conjugate on MSNs, 
bifunctional DNA–MSNs were synthesized following a previ-
ously established method, which yields MSNs with average 
pore sizes of 5.1 nm.[7] It is known that the size and density of 
mesopores, often referred to as pore volume, determine the size 
of the cargo and its loading capacity in MSNs and can be varied 
by alternative methods of colloidal synthesis.[16] To produce the 
MSN used here, thiol-functionalized MSN-1 was first prepared 
by cocondensation of (3-mercaptopropyl)trimethoxysilanes. This 
procedure also allowed to incorporate fluorescent Cy5 or Cy3 
dyes as internal labels.[6] The obtained MSNs were character-
ized by transmission electron microscopy (TEM, see Figure S16  
in the Supporting Information) and dynamic light scattering 
(DLS, see Table S5 in the Supporting Information). DLS meas-
urements revealed that MSN-1 was monodispersed in water 
(polydispersity index < 0.1) with a hydrodynamic size of ≈113 nm, 
which is bigger than the TEM size (97 ± 6 nm). The amount 
of thiol groups on the particle surface was found to be about 
256 µmol g−1, as determined by Ellman’s assay. Modification 
with two orthogonal DNA oligonucleotides was achieved in two 
consecutive steps (Figure 3). The thiol groups on the MSN sur-
face were initially activated with 2,2′-dithiodipyridine (DTDP) to 
yield MSN-2. These particles were then allowed to bind a first 
thiolated oligomer (tcF9, MSN-3) followed by brief washing and 
coupling of the second oligomer (tcF10) to yield MSN-4.
Quantification of the amounts of oligonucleotides bound 
to the MSN indicated that the amount of the first applied oli-
gomer (tcF9) was larger than that of the second applied oligo-
nucleotide tcF10 (Table S5, Supporting Information). However, 
the amounts of tcF10 were still sufficient to facilitate the surface 
assembly of the particles (see below). The resulting particles 
MSN-4 were then allowed to bind GX–F9 to yield mesopore-
capped MSN-5 (Figure 3). Determination of an increased hydro-
dynamic size, variation in the zeta potential, and changes in the 
density of functional groups (Table S5, Supporting Informa-
tion) indicated the successful installment of the gatekeeper. The 
successful hybridization of G1–F9 onto the MSN-5 particles was 
also confirmed by fluorescence spectroscopy (Figure 4A), where 
the emission spectrum showed a clear peak at 510 nm, which is 
Figure 2. Release of DNA–protein gatekeeper conjugate from magnetic microbeads. A) Schematic illustration for the workflow of the assay. B) Time-
dependent collagenase-type-IV-mediated release of the GX–F9 conjugates, as determined by fluorescence analysis of the supernatant in either the 
presence (+) or absence (−) of collagenase IV. C) SDS-PAGE analysis of MMP-2, -9, -14 mediated hydrolysis of G1–F9. For similar investigations of the 
G2–F9 and G3–F9 conjugates, see Figure S14 in the Supporting Information.
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indicative for the EGFP emission. Furthermore, the presence of 
G1–F9 on the MSN-5 surface was proven by SDS-PAGE 
analysis of the constructs, where the appearance of a band at 
≈38 kDa indicated the presence of G1–F9 (lane 3, in Figure 4B). 
It could be shown that G1 was released from the particle surface 
after the treatment of MSN-5 with collagenase type IV (lane 8).
Since HT1080 cells are known for high overexpression of 
MMPs,[17] we selected this cell line as the model for the MMP-
responsive studies. Therefore, a conditioned medium from 
HT1080 cells was also tested, whether sufficient amounts of 
MMPs were secreted to cleave G1–F9 from MSN-5 (Figure S17, 
Supporting Information). As indicated by western blot 
analysis, the presence of uncleaved G1–F9 suggested that the 
concentration of MMPs secreted by HT1080 cells is not suffi-
ciently high in the medium to allow for cleavage of all conju-
gates from the particle surface. We still considered this result 
as promising for the planned surface-based studies, as the local 
concentration of MMPs should be significantly higher in the 
immediate vicinity of the cells.
2.4. Release Studies
As a model substance for cargo release, we selected the proa-
poptotic peptide KLA (sequence: RRRRRRRGGKLAKLAK-
KLAKLAK, molecular weight 2.7 kDa),[18] which was synthesized 
Figure 3. Schematic illustration of the synthesis of DNA–protein-gatekeeper-functionalized MSNs. All MSN particles contained internal Cy5 labels. 
Note that MSN-4 particles are bifunctional due to the presence of two orthogonal DNA sequences (cF9, cF10), one of which can be used for install-
ment of the gatekeeper whereas the other one can be used for DNA-directed immobilization on glass surfaces patterned with complementary capture 
oligonucleotides.
Figure 4. Characterization of MSN-5. A) The representative emission spectrum of MSN-5 using an excitation wavelength of 460 nm. B) 16% SDS-PAGE 
analysis of MSN-5 treated with or lacking collagenase type IV.
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using Fmoc-solid phase peptide synthesis method and labeled 
with a Cy3 dye at the N-terminus. Initial release studies were car-
ried out in homogeneous solution. To this end, the model cargo 
KLA was sonicated with MSN-4 for 15 min, followed by incu-
bation at room temperature overnight before pore sealing was 
achieved by incubation with GX–F9 (see Figure 3). After removal 
of excess GX–F9 by washing the particles with buffer, the 
loading capacity of KLA was calculated to be 15.7 ± 2.1 µg mg−1. 
The cargo-loaded particles (denoted as MSN-6@GX–F9, see 
Figure  3) were then subjected to collagenase IV (final concen-
tration: 0.5 mg mL−1, see Figure S18 in the Supporting Infor-
mation) treatment and the released KLA was monitored by 
fluorescence spectroscopy at variable time points.
We observed that KLA could not be released from MSN-6@
G1–F9 at neutral pH, even in the case of open mesopores 
(Figure S19, Supporting Information). Presumably, the posi-
tive charge of KLA mediates a strong adsorption to the nega-
tively charged MSN surface, similar as previously observed for 
the release of doxorubicin from aptamer-gated MSNs.[7] Under 
acidic conditions, however, ≈100% of G1 protein was cleaved, 
and ≈80% of KLA was released from the mesopores in the 
presence of collagenase IV (Figure 5). By contrast, only ≈20% 
of KLA was released in the absence of collagenase (Figure 5B). 
Likely, this proportion corresponds to the amount of KLA that is 
unspecifically adsorbed on the MSN surface and/or embedded 
in unsealed pores. Nevertheless, the results indicated that the 
designed MMP-responsive G1–F9-capped MSNs indeed have 
the appropriate functionality to be used for surface-based cell 
studies.
2.5. Cell Studies on MSN-Patterned Surfaces
Having shown the basic functioning of the MMP-responsive 
G1–F9-capped MSNs, we now wanted to exploit the constructs 
for surface-based cell studies. To this end, we used microcon-
tact printing[7] to pattern glass substrates with the captured oli-
gonucleotide aF10 that is complementary to the cF10 oligomer 
attached to the MSN surface (see Figure  3). These surfaces 
were then used for immobilization of MSNs. In initial experi-
ments, we investigated the adhesion of HT1080 cells on line 
patterns decorated with MSN-4 (containing cF9 and cF10 oli-
gonucleotides, see Figure 3). HT1080 cells were then seeded on 
MSN-4-decorated line patterns and cultured under the standard 
conditions for 24 h, followed by cell fixation with paraformalde-
hyde (PFA) and cell staining with Alexa 546-labeled phalloidin 
and Hoechst 33342. Similar as previously reported for adhesion 
of MCF7 cells on aptamer-gated MSN patterns,[7] we found that 
the majority of HT1080 cells (≈85%) adhered to the particle-dec-
orated line patterns (Figure S20, Supporting Information), thus 
indicating that the particle-decorated surfaces exhibit a greater 
attractiveness for the cells than the unmodified glass surface.
Next, adhesion of HT1080 cells to patterned substrates deco-
rated with DNA–protein-gatekeeper-capped MSN-5 revealed 
that ≈65% of HT1080 cells preferred to bind on the MSN-
5-decorated lines (Figure 6). The somewhat lower selectivity, as 
compared to MSN-4 surfaces, can be explained by the presence 
of a protein layer on the MSN-5, which leads to a weakened 
interaction with the cell membrane, as compared to “naked” 
DNA-modified particle surfaces that are known to interact 
strongly with the cell membrane.[6]
Surprisingly, we also observed that the EGFP fluorescence 
of G1 was not detectable in the surface-immobilized MSN-5 
patterns, presumably due to surface-induced quenching of 
the EGFP fluorescence (Figure S21, Supporting Information). 
However, the quenching of EGFP fluorescence was reversible, 
as indicated in the cell adhesion experiment, wherein various 
cells on the MSN-5 patterns showed a clear EGFP fluorescence 
signal in the cytosol (Figure 6C). Since the stable DNA linker 
in between the particle and the glass surface prohibits cel-
lular uptake,[6,7] the MSN-5 particles were not ingested by the 
adhered HT1080 cells (Figure S22, Supporting Information). 
Therefore, the appearance of the EGFP signal indicated that the 
G1 protein was cleaved by MMPs secreted by the adhered cells 
and subsequently ingested by the cells.
To investigate whether incorporated KLA cargo has an influ-
ence on cell adhesion and can be released from the surface, 
HT1080 cells were then seeded on MSN-6-decorated line pat-
terns. To this end, Cy3-labeled KLA (Cy3–KLA) was loaded into 
the particles, and the resulting particles MSN-6 (Figure  3; for 
physicochemical characterization, see Table S6 in the Sup-
porting Information) were used for the preparation of the 
micropatterned surfaces, as described above. Since MSN-6 do 
not contain the protein gatekeeper, we found that the majority 
of the cells (≈89%) adhered to the MSN-decorated lines 
(Figure S23, Supporting Information), as it was observed for 
Figure 5. Release of A) G1 protein and B) Cy3-labeled KLA from MSN-6@G1–F9 under acidic conditions at pH 5.3.
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the purely DNA-modified MSN-4 (Figure 6E). Moreover, a dis-
tinctive Cy3 signal appeared in cell’s cytosol (Figure S23, Sup-
porting Information), indicating that the Cy3-labeled KLA cargo 
was released from the particles and taken up by the cells.
To further investigate the functionality of the developed gate-
keeper conjugates, HT1080 cells were then seeded on line pat-
terns decorated with KLA-loaded MSN-6@G1–F9 (see Figure 3). 
After 24 h of incubation, the cells were fixed with PFA and 
stained to enable microscopy inspection. It is shown in Figure 7 
that cells on the lines decorated with the cleavable gatekeeper 
constructs (MSN-6@G1–F9), revealed the fluorescent signals 
of both the EGFP of the G1 gatekeeper as well as of Cy3–KLA. 
This observation clearly indicated the successful cleavage of the 
gatekeeper from the particle surface, which led to release and 
uptake of the G1 protein and the Cy3–KLA cargo. By contrast, 
no intracellular fluorescent signal of EGFP or Cy3–KLA could 
be observed in the case of the cells adhered to the lines deco-
rated with the uncleavable gatekeeper constructs (MSN-6@
G4–F9, see Figure S24 in the Supporting Information). Hence, 
these results indicated the successful development of MMP-
cleavable MSN constructs, which are functional on the solid 
surface under cell culture conditions.
To test the cytotoxic effect of the KLA-loaded “biopebble 
containers,” HT1080 cells were seeded on line patterns 
decorated with MSN-6@G1–F9 that was loaded with unla-
beled KLA to prevent interference of the Cy3 label with the 
fluorescence of propidium iodide (PI). PI staining revealed 
that about 15% of the cells on the pattern could be identi-
fied as dead cells (Figure S25, Supporting Information). 
This amount was somewhat lower than that observed in 
control experiments, wherein a homogeneous suspension 
of MSN-6@G1–F9 was applied to HT1080 cells (about 40% 
reduction of cell viability, see Figure S26 in the Supporting 
Information). The relatively low cytotoxicity of KLA is in 
agreement with the literature,[18b] indicating that this peptide 
is nontoxic to the majority of eukaryotic cells’ reduction. We 
attribute the decrease in toxicity observed for the surface-
based KLA delivery to the fact that dead cells cannot adhere 
longer strongly to the solid substrate and thus are washed 
away during the PI staining process.
Finally, we also confirmed that lines bearing KLA-loaded MSNs, 
which were capped either with a cleavable (MSN-6@G1–F9) 
or a noncleavable gatekeeper (MSN-6@G4–F9), have a signifi-
cant effect on HT1080 cell adhesion. To demonstrate this in a 
Figure 6. HT1080 cells adhered on an MSN-5-decorated line pattern. A) MSN-5 (red) immobilized on the micropatterned aF10 oligonucleotide lines. 
B) Cell nuclei (blue) of HT1080 stained with Hoechst 33342. C) EGFP signal (green) of the G1 protein. Note that several cells adhered on the MSN-5 
patterns reveal the EGFP fluorescence, thus suggesting that the protein was cleaved by MMPs and ingested by the cells. D) Merge. E) Statistical 
analysis of cells bound on or off the MSN-5-decorated pattern. Note that ≈65% of HT1080 cells preferred to adhere on MSN-5-decorated line patterns 
(n = 4, ≈1000 cells were counted).
Small Methods 2021, 2001049
www.advancedsciencenews.com www.small-methods.com
2001049 (8 of 9) © 2021 The Authors. Small Methods published by Wiley-VCH GmbH
single experiment, we used cross-patterned lines on which 
either MSNs with the cleavable or noncleavable gatekeeper were 
immobilized using orthogonal DNA hybridization (Figures S27 
and S28, Supporting Information). The results clearly showed 
that the immobilization of the two different DNA oligonucleo-
tides used for this purpose led to no differences in cell adhesion 
(Figure S27, Supporting Information). However, the presence 
of a cleavable or noncleavable gatekeeper caused a significant 
≈1:2 difference in the number of cells growing on KLA-loaded 
MSN-6@G1–F9 or MSN-6@G4–F9, respectively (Figure S28, 
Supporting Information).
This drastic decrease in cells on lines decorated with KLA-
loaded MSNs equipped with cleavable gatekeepers clearly indi-
cates that the cell-triggered release of the cytotoxic agent leads 
to highly localized concentrations able to primarily affect the 
cells in close contact with the particles. For adjacent cells that 
are separated only by a distance of a few micrometers and that 
are growing on MSNs where the release of the cytotoxic peptide 
is hindered by the noncleavable gatekeeper system, the local 
concentration of KLA is substantially lower, which manifests 
in the higher cell count. The attractiveness of MSNs for cell 
adhesion in combination with the highly localized delivery of 
active agents makes the described system a well-suited tool for 
studying the interaction of various cells and tissues with bioac-
tive surfaces.
3. Conclusions
In summary, we here reported on the development of a cell-
responsive biohybrid interface that can be used for spatially 
confined release of molecular cargo. By taking full advantage 
of the highly specific Watson–Crick base pairing of comple-
mentary DNA oligonucleotides, we designed a bottom-up 
approach for the DNA-directed assembly of protein-gated 
MSNs and their DNA-mediated immobilization on micro-
structured surface patterns. Of particular importance is the 
enormously high modularity of the system presented here. On 
the one hand, any other DNA–protein gatekeeper conjugates 
can be used instead of the EGFP used here for sealing the 
mesopores of the MSNs. For example, by incorporating spe-
cific recognition peptides, other proteases secreted by cells can 
be used as effectors for the release of the encapsulated cargo, 
or other bulky proteins can be made available for uptake into 
the cytosol by cell-based cleavage. On the other hand, orthog-
onally addressable oligonucleotides can be installed on the 
MSN surface and harnessed to achieve site-specific immobili-
zation on solid substrates. This allows the production of mul-
ticolored surface patterns on planar glass surfaces, as shown 
in this work. Another advantage of the system described here 
stems from the unique properties of DNA linkers. While 
DNA can be degraded by a variety of nucleases, we have not 
Figure 7. Representative fluorescence microscopy images of HT1080 cells adhered onto KLA-loaded MSN-6@G1–F9-decorated line patterns. A) Cy5 
fluorescence (red) of MSN-6@G1–F9. B) Cy3–KLA (magenta). C) Cell nuclei of Hoechst 33342-stained HT1080 cells. D) EGFP fluorescence (green) 
of the released G1 gatekeeper in the cytosol of the cells. E) Merge. F) Statistical analysis of cells bound on or off the MSN-6@G1–F9-decorated line 
patterns. Note that ≈65% of HT1080 cells adhered to the MSN-6@G1–F9-decorated line patterns (n = 4,  ≈600 cells were counted).
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observed this process unintentionally in any of our previous 
studies of DNA-directed assembly of proteins and nanopar-
ticles.[19] The stability of the system is also clearly evident in 
the present study, as the DNA linker shows sufficient stability, 
even under cell culture conditions, to prevent cleavage of the 
particles from the surface and subsequent cellular uptake (see, 
e.g., Figure S22 in the Supporting Information). On the other 
hand, sequence features can be specifically incorporated into 
the linkers to induce cleavage in a targeted manner and thus 
enable release of surface immobilized components. It should 
also be possible to integrate such MSN constructs by hybridi-
zation into soft 3D DNA materials, such as DNA-based hydro-
gels and composite materials.[20] In addition, the DNA-based 
assembly system offers the possibility to couple the respon-
sive MSN constructs with complex functional nanostructured 
ligand arrangements to create bioinstructive material systems 
applicable for cell culture, tissue engineering, or other areas of 
nanobiotechnology.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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